Evidence map›Paper›PMID 36940058›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2024

Oxidized Activated Charcoal Nanozymes: Synthesis, and Optimization for In Vitro and In Vivo Bioactivity for Traumatic Brain Injury.

Emily A McHugh, Anton V Liopo, Kimberly Mendoza, Claudia S Robertson, Gang Wu, Zhe Wang, Weiyin Chen, Jacob L Beckham, Paul J Derry, Thomas A Kent and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Nanozyme-based therapeutic strategies for traumatic brain injury.International journal of pharmaceutics: X · 2026
    Review
  2. Smart Nanotechnologies for Multimodal Neuromodulation and Brain Interfacing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Emily A McHughDepartment of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.
Anton V LiopoInstitute of Biosciences and Technology, Texas A&M Health Science Center, 2121 W. Holcombe Street, Houston, TX, 77030, USA.ORCID https://orcid.org/0000-0003-4218-2159
Kimberly MendozaDepartment of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.
Claudia S RobertsonDepartment of Neurosurgery, Baylor College of Medicine, Houston, TX, 77030, USA.
Gang WuHematology, Internal Medicine, University of Texas McGovern Medical School-Houston, Houston, TX, 77030, USA.
Zhe WangDepartment of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.
Weiyin ChenDepartment of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.
Jacob L BeckhamDepartment of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.
Paul J DerryInstitute of Biosciences and Technology, Texas A&M Health Science Center, 2121 W. Holcombe Street, Houston, TX, 77030, USA.ORCID https://orcid.org/0000-0001-6791-8586
Thomas A KentDepartment of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.ORCID https://orcid.org/0000-0002-9877-7584
James M TourDepartment of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.
Rice University · USTexas A&M Health Science Center · USBaylor College of Medicine · USWelch Foundation · US

Funding

Novel Carbon Nanozyme Mechanisms for Traumatic Brain InjuryR01NS094535 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI HEGDE, MURALIDHAR L, KENT, THOMAS · 2015 to 2024
$4.1M
Defining the altered FUS-PARP-1-DNA Ligase III axis and its implications to nuclear and mitochondrial genome damage response in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)RF1NS112719 · NINDS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI HEGDE, MURALIDHAR L · 2020 to 2020
$2.0M
Augmenting carbon nanoparticles as novel antioxidants for ischemic strokeR21NS084290 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI KENT, THOMAS, TOUR, JAMES MITCHELL · 2014 to 2015
$435k
NIH HHS R01NS094535NIH HHS R21NS084290NINDS NIH HHS R01 NS094535NINDS NIH HHS R21 NS084290NINDS NIH HHS RF1 NS112719
6 · The paper itself

Abstract

Carbon-based superoxide dismutase (SOD) mimetic nanozymes have recently been employed as promising antioxidant nanotherapeutics due to their distinct properties. The structural features responsible for the efficacy of these nanomaterials as antioxidants are, however, poorly understood. Here, the process-structure-property-performance properties of coconut-derived oxidized activated charcoal (cOAC) nano-SOD mimetics are studied by analyzing how modifications to the nanomaterial's synthesis impact the size, as well as the elemental and electrochemical properties of the particles. These properties are then correlated to the in vitro antioxidant bioactivity of poly(ethylene glycol)-functionalized cOACs (PEG-cOAC). Chemical oxidative treatment methods that afford smaller, more homogeneous cOAC nanoparticles with higher levels of quinone functionalization show enhanced protection against oxidative damage in bEnd.3 murine endothelioma cells. In an in vivo rat model of mild traumatic brain injury (mTBI) and oxidative vascular injury, PEG-cOACs restore cerebral perfusion rapidly to the same extent as the former nanotube-derived PEG-hydrophilic carbon clusters (PEG-HCCs) with a single intravenous injection. These findings provide a deeper understanding of how carbon nanozyme syntheses can be tailored for improved antioxidant bioactivity, and set the stage for translation of medical applications.

Indexed as

AntioxidantsBrain Injuries, TraumaticOleic AcidsAnimalsCarbonCharcoalChlorambucilMiceRatsSuperoxide DismutaseAntioxidantsCarbonCharcoalChlorambucilchlorambucil-oleic acid conjugateOleic AcidsSuperoxide Dismutaseantioxidantscarbon nanotechnologynanozymesoxidized activated charcoalsuperoxide dismutase mimetic

Identifiers

PMID36940058
PMCPMC10509328
OpenAlexW4327898024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.